Drugs / Ularitide
Ularitide
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00487799 | — | congestive heart failure | Facet Biotech | Withdrawn | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT04311489 | Aug 2020 → Nov 2022 | cirrhosis of liver | University of Aarhus | Terminated | No outcome recorded |
| Phase 2 | NCT00390624 | Jul 2003 → Dec 2006 | acute kidney injury, impaired renal function disease | Rocky Mountain Cancer Centers | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01661634 | Jul 2012 → Nov 2015 | heart failure | Cardiorentis | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ULARITIDE | “URODILATIN (ULARITIDE, ATRIAL NATRIURETIC PEPTIDE)” NCT00390624 ↗ |
| Known as | Ularitida | ChEMBL registry synonym — accepted as the source's own label CHEMBL2103920 ↗ |
| Known as | Ularitide acetate | ChEMBL registry synonym — accepted as the source's own label CHEMBL2103920 ↗ |
| Known as | Urodilatin | “Ularitide (Urodilatin) Intravenous Infusion” NCT01661634 ↗ |
| Known as | Urodilatin ularitide | ChEMBL registry synonym — accepted as the source's own label CHEMBL2103920 ↗ |
| Modality | Peptide | “URODILATIN (ULARITIDE, ATRIAL NATRIURETIC PEPTIDE)” NCT00390624 ↗ |
| Modality | Protein / enzyme biologic | — CHEMBL2103920 ↗ |
| Route | Intravenous | “continuous intravenous (IV) ularitide infusion” NCT01661634 ↗ |